08:00 , Nov 23, 2009 |  BC Week In Review  |  Clinical News

2-iminobiotin regulatory update

EMEA's Committee for Orphan Medicinal Products (COMP) issued a positive opinion to grant Orphan Drug designation for Neurophyxia's 2-iminobiotin to treat perinatal asphyxia (oxygen shortage at birth). The cyclic guanidino analog of biotin has Orphan...